Latest Media Releases (Page 10) | Finance News Network

Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Next Science - Investor Presentation - Q3 2023 (ASX:NXS)

To view the Investor Presentation, download the attached PDF.

Next Science - Quarterly Activity Report - 30 September 2023 (ASX:NXS)

Highlights: Discipline and diligence around quality of revenue realised significant increase in Gross Margin. Quarterly Gross Profit increased from $2.4m to $3.8m yoy. 3QFY2...read more

Next Science - Appendix 4C - 30 September 2023 (ASX:NXS)

To view the Appendix 4C, download the attached PDF.

Chimeric Therapeutics - New data for Phase 1A CLTX CAR T brain cancer clinical trial (ASX:CHM)

A 55% Disease Control Rate (DCR) was achieved in patients treated with CLTX CAR T, exceeding historical disease control rates of 20-37%1 ~10 months median survival was demonstr...read more

Immutep - Webcast slides for new Efti clinical data in 1st line NSCLC (ASX:IMM)

To view the presentation, download the attached PDF.

Immutep - Excellent Overall Survival in Non-Small Cell Lung Cancer (ASX:IMM)

Median Overall Survival reaches 35.5 months in first-line treatment of metastatic non-small cell lung cancer patients expressing PD-L1 (TPS >1%), 23.4 months in patients with...read more

Immutep announces publication of ESMO 2023 abstracts (ASX:IMM)

New updated data from TACTI-002, including more mature Overall Survival data, will be presented during the Mini Oral session on Saturday, October 21st, at 9:05 CEST Immute...read more

RAD receives approval for Phase 1 therapeutic study of NSCLC (ASX:RAD)

Sydney, Australia – 9 October 2023 – Radiopharm Theranostics (ASX:RAD), a developer of a worldclass platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is ...read more

Immutep announces acceptance of abstract for SITC 2023 (ASX:IMM)

SYDNEY, AUSTRALIA – 3 October 2023 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing...read more

Austco Healthcare - Acquisition agreement for Teknocorp executed (ASX:AHC)

Highlights -- Agreement executed to acquire 100% of the business and assets of Teknocorp, a communications hardware and software solutions provider and certified Austco Nurse Call reseller (&ldqu...read more

Next Science - Successful completion of Share Purchase Plan & US Offer (ASX:NXS)

Sydney, Australia Friday, 22 September 2023, Next Science Limited (ASX:NXS) (Next Science or the Company), a medical technology company focused on commercialising its proprietary XBIO™ suite o...read more

Immutep - Commercial Scale Manufacturing of Efti for Clinical Trials (ASX:IMM)

SYDNEY, AUSTRALIA – September 21, 2023 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company develop...read more

INOVIQ - ASX Small and Mid-Cap Conference Investor Presentation (ASX:IIQ)

To view the presentation, download the attached PDF.

Austco Healthcare Investor Presentation (ASX:AHC)

To view the presentation, download the attached PDF.

Paragon Care - Appointment of New CEO and Managing Director (ASX:PGC)

Paragon Care Limited (ParagonCare/Company) a premier provider of medical equipment, devices, blood products and consumables across Australia, New Zealand and Asia has today announced the resignation...read more

Viewing: 136 - 150 of 200 Previous | Next